Related Experiment Video
Updated: Jun 4, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Long-term blood pressure control: what can we do?
1Orange County Research Center, Tustin, CA 92780, USA. jmneutel@aol.com
Insights
Uncontrolled hypertension affects many high-risk patients. Combining calcium channel blockers (CCB) and angiotensin receptor blockers (ARB) offers a simpler, more effective approach to long-term blood pressure control.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Long-term blood pressure (BP) control in hypertension presents unique challenges for primary care physicians.
- Up to one-third of high-risk patients experience uncontrolled hypertension, increasing risks for cardiovascular disease, stroke, heart failure, and kidney disease.
- Patient non-adherence to medication regimens, due to tolerability, complexity, or cost, complicates long-term BP management.
Purpose of the Study:
- To discuss challenges in long-term hypertension management.
- To evaluate combination therapy as a strategy for improving BP control.
- To highlight the benefits of calcium channel blocker (CCB)/angiotensin receptor blocker (ARB) combinations.
Main Methods:
- Review of clinical trial data on combination antihypertensive therapy.
- Analysis of CCB/ARB combinations for efficacy and adherence.
- Consideration of combination therapy as a first-line approach.
Main Results:
- Combination therapy, specifically CCB/ARB, can reduce side effects and improve patient adherence.
- This approach is effective for patients unresponsive to monotherapy or not meeting BP goals.
- Fixed-dose CCB/ARB combinations offer economic and regimen-simplification benefits.
Conclusions:
- CCB/ARB combination therapy is a compelling alternative for long-term hypertension management.
- This strategy aids in achieving target blood pressure goals more rapidly.
- Combined with supportive measures, CCB/ARB combinations enhance patient outcomes in hypertension treatment.
Abstract:
There are unique problems associated with the long-term control of blood pressure (BP) in patients with hypertension. Many of these problems warrant specific discussion for the primary care physician. Up to one-third of high-risk patients are estimated to have uncontrolled hypertension. Although long-term control is essential to avoid complications of cardiovascular disease, such as myocardial infarction, stroke, heart failure, and kidney disease, it can become troublesome because of challenges with patient compliance and adherence to medication regimens. This may be due to low tolerability profiles, complicated regimens, or prohibitive costs. Trials have shown that a combination approach may reduce side effects with complementary therapies such as a calcium channel blocker (CCB)/angiotensin receptor blocker (ARB) combination. Combination therapy can be used in any patient group not responsive to monotherapy, or who remain 20 mm Hg higher than their BP goal. This method may achieve the goal of reaching target BP sooner as a first-line approach and, in a fixed-dose combination, may be a more economic choice as well as a simpler regimen for the patient. Together with supportive measures, CCB/ARB combinations are a compelling alternative for the long-term treatment of hypertension.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Atherosclerosis III: Management
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure